AstraZeneca plc
Bayer AG
Boehringer Ingelheim International GmbH
Bristol Myers Squibb (BMS)
Eisai Co. Ltd. F. Hoffmann-La Roche AG
Johnson & Johnson
Novartis International AG
Pfizer Inc. Roche Holding AG
Published | Pages | Publisher | Report code |
---|---|---|---|
Jun 2022 | 77 | GEN Consulting | ASDR-601400 |
AstraZeneca plc
Bayer AG
Boehringer Ingelheim International GmbH
Bristol Myers Squibb (BMS)
Eisai Co. Ltd. F. Hoffmann-La Roche AG
Johnson & Johnson
Novartis International AG
Pfizer Inc. Roche Holding AG